mass ions monitored at a dwell time of 20 ms. A multipoint calibration curve (25-500 g/L) and pentadeuterated internal standards (Radian Corp., Austin, TX) were used for quantification; i.e., quantification was based on the ion peak area ratio of the analyte to its corresponding pentadeuterated internal standard analog. The limit of quantification (LOQ) was established as 25 g/L. Analytes were identified on the basis of retention time (Ϯ1%) and ion ratios (Ϯ20%) by comparison with the corresponding values for the internal standards.
Manual pretreatment with enzyme before immunoassay analysis can be very time consuming. By using ␤-glucuronidase added to the R1 reagent of the CEDIA benzodiazepine assay and subsequent on-line incubation with the urine specimen, conjugated benzodiazepines were cleaved to yield more immunoreactive analytes. Compared with the current CEDIA, the modified CEDIA demonstrated a 26% increase in the number of presumptive positive results, from 37 to 50 specimens. Furthermore, all benzodiazepine-positive specimens demonstrated an increase in ⌬ absorbance rates (mA/min) with the modified assay, the increase ranging from 10 to 269 (mean, 72.56; SD, 70.19).
Results of the GC/MS analyses for the specimens that were negative by the current CEDIA, but positive by the modified CEDIA, are listed in Table 1 . The data demonstrate that ␤-glucuronidase pretreatment improves immunoassay detection of several benzodiazepine analytes, even at concentrations less than the cutoff calibrator. Benzodiazepine analytes for which detection was improved include lorazepam, nordiazepam, oxazepam, and temazepam. Of the 50 total specimens, 3 could not be confirmed by the chosen GC/MS assays and were subse-quently submitted to BMC for analysis by alternative GC/MS methods. Two of these specimens were found to be positive for oxaprozin, and one was positive for alprazolam. Combining these GC/MS results with the CEDIA screening results gives a specificity of 99.8% for the current and modified CEDIA methods.
Our study shows that addition of ␤-glucuronidase to the R1 reagent of the CEDIA DAU benzodiazepine assay increases the detection of benzodiazepine analytes in urine specimens. To confirm the presence of benzodiazepine analytes in urine, a technique should be able to detect concentrations less than the immunoassay cutoff value. This sensitive on-line hydrolysis method provides a rapid and efficient urine screen for the presence of benzodiazepines.
This study was funded in part by Boehringer Mannheim Corp. PCR [1] [2] [3] [4] [5] . Compared with conventional methods, CGE analysis offers higher resolution and better reproducibility and is capable of direct quantification and automation. CGE coupled with laser-induced fluorescence (LIF) system can detect as few as six molecules of stained DNA [6] . Meanwhile, the most popular CGE/LIF detection involves the use of fluorescent DNA intercalating dyes, including ethidium bromide, YO-PRO3, and SYBR Green I [7] . However, efficient separations are obtained only over a narrow range of DNA-dye ratios [8] . In some cases, broad peaks may result from the presence of multiple dye-DNA binding. Fluorescent DNA derivatives obtained by covalent binding of DNA with fluorescent dye is more stable and may be more suitable for CGE/LIF analysis. Previously, an activated cyanine dye (Cy-5), which can be readily coupled with peptide, proteins, and amino-linked oligonucleotides [9] , was synthesized. The dye contains two broad absorption maxima at 630 and 655 nm with a very high absorptivity and fluorescence quantum yield. Cy-5-labled molecules are suitable subjects for LIF detection with a semiconductor laser source emitting at 653 nm. Chen et al. have reported synthesis and CE/LIF detection of a Cy-5-conjugated M 13 primer [10] . It thus follows that fluorescent PCR products could be obtained if the primers used were first conjugated with Cy-5 dye. In this report, molecular diagnosis of a mitochondrial DNA genetic disease, MELAS (myopathy, en-cephalopathy with lactic acidosis and stroke-like episodes) [11, 12] , was used as a model for investigating the feasibility of CGE/LIF analysis of Cy-5-labeled PCR product and its restriction fragments. A P/ACE 5500 CE equipped with a 2.5 mW diode laser emitting at 652 nm and a LIF detector (Beckman Instruments) was used for the CE runs. Capillary columns, typically of 27 cm length (20 cm to detector window) ϫ 50 m i.d., were assembled in the P/ACE cartridge format. The columns were silaned with ␥-methacrylopropyltrimethoxysilane (Sigma) for 2 h and coated with 2% polyacrylamide for 1 h as described by Figeys et. al [4] . The cathode was set on the injection side. Before each separation step, the coated column was filled with replaceable gel buffer [4% linear polyacrylamide in TB buffer (0.1 mol/L Tris, 0.25 mol/L borate, pH 8.3)] by high-pressure [103.4 kPa (15 psi)] rinsing for 3 min. Electrophoresis was performed with TB buffer at a field strength of 500 V/cm. Postrun data analysis was performed with System Gold TM (version 8.0) software (Beckman Instruments).
Analysis of Cyanine Dye-Labeled PCR Product and Restriction Fragments by Capillary Electrophoresis and
The PCR primers used for amplfying the 739-bp mitochondrial DNA sequence encompassing the MELAS-3243 mutation site were selected with Oligo 40-S software (a multifunctional program for selecting appropriate oligonucleotides for DNA amplification). The primer sequences were: (forward) 5Ј-(2715)AGACGAGAAGACCCTATGGA(2734)-3Ј and (reverse) 5Ј-(3473)AAGAGTTTTATGGCGTCAGC(3493)-3Ј. The prim- Samples were electrophoresed with 4% linear polyacrylamide at a field strength of 500 V/cm on a 50 m (i.d.) coated capillary column. Relative migration times of the DNA fragments with respect to the primer are indicated in parentheses. ers were synthesized with a hexylamino terminus at its 5Ј end by Applied Biosystems. Both 5Ј-amino-linked forward and reverse primers (30 nmol each) dissolved in 300 L of 100 mmol/L Na 2 CO 3 (pH 9.5) were added to the Cy-5 dye vial from Amersham and allowed to stand at room temperature for 60 min. Fifty microliters of the conjugation mixture was loaded on a G-25 spin column and centrifuged at 1000g for 1 min to obtain purified Cy-5-labeled primer. All the conjugation and purification steps were monitored by CGE/LIF. The samples were hydrodynamically injected for 2 s under low pressure [3.45 kPa (0.5 psi)]. As demonstrated in Fig. 1A , in the conjugation mixture, the Cy-5-labeled primers migrate in front of Cy-5 diacid, which is a hydrolyzed product of Cy-5 in an alkaline condition [10] . After G-25 spin column purification, Cy-5 diacid was almost completely absorbed, while the labeled primer was all spun down without a decrease of concentration (Fig. 1B) . Less than one microliter of the purified, labeled primer mixture was enough for a PCR reaction.
MELAS disease has been characterized by a major point mutation (A to G at 3243) in mitochondrial DNA. An ApaI restriction digestion site is generated at the site of mutation [12] . Muscle DNA extracted from a MELAS patient with Puregene DNA purification kit (Gentra) was used as a positive control. The sequence encompassing the MELAS mutation site was PCR-amplified with the Cy-5labeled primer mixture according to the conditions described by Goto et al. [12] to generate a 739-bp PCR product. The MELAS-specific PCR product can be digested by ApaI into 211-and 528-bp restriction fragments. The size of the DNA fragments were verified by 2% agarose gel electrophoresis with X174 as the size marker (data not shown). For CGE/LIF analysis, the undiluted PCR-amplified mixture was hydrodynamically injected for 60 s with a prior injection of 0.1 mol/L Tris acetate (pH 8.3), which may improve peak resolution as described by Van der Schan et al. [13] . As demonstrated in Fig. 1C , the PCR product was detected at 7.2 min. After ApaI digestion, the two restriction fragments appeared at 5.7 min and 6.9 min and were well separated from the undigested PCR product (Fig. 1D ). The relative migration times (RMTs) of the PCR product and its restriction fragments with respect to the fastest moving primer (as indicated in the parentheses) are highly reproducible. The intraday and interday precisions for the RMT of each peak, expressed as CV (n ϭ 5), were Ͻ0.08% and 0.12%, respectively.
The concentrations of the PCR products were determined by the peak heights expressed as relative fluorescence units (RFUs) on the CGE/LIF electropherogram based on the calibration factor generated from serial dilutions of the PCR product with known concentration determined by a DNA concentrator (DyNA Quant 200 from Hoefer). To do this, MELAS PCR mixture with no excess primer was obtained by performing 45 thermal cycles. Serial 10-fold dilutions of such pure MELAS PCR product were analyzed by CGE/LIF. The peak height of each fragment was plotted against the concentration of the PCR product over the range of 5 ng/L to 50 g/L, within which a linear relation was obtained (data not shown). As each PCR product contains two Cy-5 molecules (conjugated with the forward and reverse primers), the fluorescence intensity of the Cy-5-labeled PCR product is in proportion to its molar concentration. The limit of detection of the 739-bp PCR product was ϳ3 ng/L (equal to 500 fmol/L) determined at 4:1 signal-to-noise ratio.
CGE/LIF detection of fluorescent PCR product derived from Cy-5-labeld primer is highly specific and reproducible. Apart from its application in the area of molecular diagnosis, this methodology has great potential in many areas such as gene expression and gene mutation studies.
